Skip to main content
PAHC logo
PAHC
(NASDAQ)
Phibro Animal Health Corporation
$34.04-- (--)
Loading... - Market loading

Phibro Animal Health (PAHC) Stock Price & Financial Analysis

Phibro Animal Health Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$33.25 - $34.26
52-Week High$60.08
52-Week Low$25.58
Open$33.42
Volume162.05K
Average Volume (3M)281.11K
Market Cap1.40B
Shares Outstanding41.04M
P/E Ratio (TTM)14.67
Forward P/E7.31
Price to Sales (P/S)0.93
Price to Book (P/B)3.86
EV/EBITDA9.38
Revenue (TTM)1.50B
Net Income (TTM)95.23M
Free Cash Flow (TTM)12.77M
EPS (TTM)$2.33
Profit Margin6.35%
Operating Margin12.22%
Return on Equity (ROE)26.32%
Debt to Equity2.18
50-Day MA$32.65
200-Day MA$42.66
52-Week Change14.27%
Annual Dividend$0.48
Dividend Yield1.41%
Payout Ratio20.61%
Last Dividend Ex-DateJun 3, 2026

Frequently Asked Questions About Phibro Animal Health

What is the current stock price for PAHC?

As of the latest trading session, PAHC stock trades at $34.04. The 52-week range is $25.58–$60.08, with a day range of $33.25–$34.26.

What is the P/E ratio for PAHC?

Phibro Animal Health's trailing P/E ratio is 14.7, meaning investors pay $14.7 for every $1 of annual earnings. The forward P/E is 7.3, reflecting analyst expectations for future earnings. Phibro Animal Health operates in the Healthcare sector.

Does PAHC pay dividends?

Yes, Phibro Animal Health pays a 1.41% annual dividend yield ($0.48 per share). The payout ratio is 20.6%. The last ex-dividend date was 2026-06-03.

What do analysts recommend for PAHC?

Based on 1 analyst, the consensus for PAHC is Buy.

What is the market cap of PAHC?

Phibro Animal Health's market capitalization is $1.40B, classifying it as a small-cap company. Phibro Animal Health operates in the Healthcare sector within the Drug Manufacturers - Specialty & Generic industry.